Advertisement

The Promise of Nanomedicine

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

By | April 8, 2014

WIKIMEDIA, NEMISSIMOOnly a handful of nanotherapeutics are currently on the market, but dozens more are making their way through preclinical studies and clinical trials. And the more researchers learn about the new technology, the more excited they get. In a session today (April 8) at this year's American Association for Cancer Research (AACR) meeting, researchers discussed the promises—and challenges—of this growing field.

“[Nanotechnology is] allowing people to do science, and look at cancer, in fundamentally new ways,” said James Heath of Caltech. In addition to treating disease, the panelists noted, nanotechnology could improve early-stage diagnosis and even help predict the development of drug resistance in tumors. “Success in early detection has been limited at best,” said Anil Sood from the University of Texas MD Anderson Cancer Center. “Nanotechnology offers a variety of opportunities in detection and screening.”

Mark Davis, also from Caltech, emphasized the so-far impressive safety profiles of nanotherapeutics. “With well-designed particles . . . the idea is less drug, less often, greater efficacy.” The safety profiles of some nanomedicines are so good, in fact, that researchers are able to maintain dose levels even when combined with other therapies, he noted, and studies are beginning to show evidence of long-term safety. “It’s very clear [that these products have] dramatically reduced side effects” as compared with traditional therapies, he said. “This is going to open up a lot of different combination therapies now that we couldn't do in the past.”

Amid the excitement, however, were also words of caution. “The environment is a difficult one,” said Paul Burke, principal of Burke Bioventures. “Attrition rates are high and they're getting higher. . . . There are no special rules—no grading on a curve—just because nanotechnology is exciting.”

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement

Popular Now

  1. Neanderthal-Human Hybrid Unearthed
  2. Extra DNA Base Discovered
    The Nutshell Extra DNA Base Discovered

    An epigenetic variant of cytosine is stable in the genomes of living mice, suggesting a possible expansion of the DNA alphabet.

  3. Next Generation: Smart Insulin Patch
  4. LabQuiz: Cell Health
    Sponsored Quiz LabQuiz: Cell Health

    Are you a Cell Doctor? Find out how much you really know about apoptosis, autophagy, oxidative stress, and factors affecting cell health and receive a free wallchart entitled “Apoptosis Signaling and Detection” for taking our LabQuiz.

Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist